This article discusses developments in intellectual property rights (IPR) related to biological products, suggesting potential policy actions.
The advent of new techniques in genetic manipulation has sparked discussions in IPR involving biological products and processes. This article, which has been presented during the DOST-PIDS Seminar-Discussion on “Intellectual Property Rights: Policy Issues and Perspectives” on December 13, 1991, presents the developments in this arena. Action plan is suggested.
No takes yet. Share an insight, caveat, or question.
Rosario G. Manasan (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: